HCPCS Codes Similar to J7174

HCPCS Codes Similar to “J7174” Code.
Injection, fitusiran, 0.04 mg

A4802 Protamine sulfate, for hemodialysis, per 50 mg Code added date: 20020101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON	J0604 Cinacalcet, oral, 1 mg, (for esrd on dialysis) Code added date: 20180101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
J0606 Injection, etelcalcetide, 0.1 mg Code added date: 20180101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	J0884 Injection, argatroban, 1 mg (for esrd on dialysis) Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
J0892 Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) Code added date: 20230101 Code effective date: 20230401 TXT \| PDF \| XML \| JSON	J0899 Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) Code added date: 20230101 Code effective date: 20230401 TXT \| PDF \| XML \| JSON
J0901 Vadadustat, oral, 1 mg (for esrd on dialysis) Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	J0911 Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis) Code added date: 20240701 Code effective date: 20240701 TXT \| PDF \| XML \| JSON
J1443 Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron Code added date: 20160101 Code effective date: 20211001 TXT \| PDF \| XML \| JSON	J1444 Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron Code added date: 20190701 Code effective date: 20190701 TXT \| PDF \| XML \| JSON
Q0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg Code added date: 20211208 Code effective date: 20241213 TXT \| PDF \| XML \| JSON	Q0221 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg Code added date: 20220224 Code effective date: 20241213 TXT \| PDF \| XML \| JSON
Q0222 Injection, bebtelovimab, 175 mg Code added date: 20220211 Code effective date: 20241213 TXT \| PDF \| XML \| JSON	Q0224 Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg Code added date: 20240322 Code effective date: 20240322 TXT \| PDF \| XML \| JSON